The interleukin (IL)-1 family includes 11 members that are important in inflammatory processes. It includes various agonists and two antagonists, IL-1Ra and IL-36Ra. Our aim was to investigate whether the IL-1 family is involved in allergic contact dermatitis (ACD). The expression of IL-1 family members was evaluated by PCR and mmunohistochemistry in the positive patch test reaction site (involved skin), and in the uninvolved skin of ACD patients. We also examined these cytokines in an ex vivo model of ACD. The antagonistic activity of IL-36Ra was evaluated by injecting recombinant IL-36Ra in uninvolved skin biopsies of ACD patients. IL-1Ra and IL-36Ra expression was quantified in mononuclear cells of nickel-sensitized patients challenged in vitro with nickel. IL33-involvement in ACD was investigated by intradermal injection of anti-IL-33 in the uninvolved skin of patients ex vivo. Results showed that IL-1?, IL-1Ra, IL-36?, IL-36?, IL-36? and IL-33 expression, but not IL-36Ra expression was enhanced in ACD-involved skin. Immunohistochemical analysis and ex vivo skin cultures confirmed these results. Injection of anti-IL-33 in ACD-uninvolved skin inhibited IL-8 expression, whereas IL-36Ra inhibited IL-36?, IL-36?, IL-36? and IL-8 expression. Nickel induced IL-1Ra expression in lymphocytes of nickel-sensitized patients. In conclusion, various IL-1 agonists and antagonists may be involved in ACD pathogenesis.
Expression of IL-1 family members in human allergic contact dermatitis
2013
Abstract
The interleukin (IL)-1 family includes 11 members that are important in inflammatory processes. It includes various agonists and two antagonists, IL-1Ra and IL-36Ra. Our aim was to investigate whether the IL-1 family is involved in allergic contact dermatitis (ACD). The expression of IL-1 family members was evaluated by PCR and mmunohistochemistry in the positive patch test reaction site (involved skin), and in the uninvolved skin of ACD patients. We also examined these cytokines in an ex vivo model of ACD. The antagonistic activity of IL-36Ra was evaluated by injecting recombinant IL-36Ra in uninvolved skin biopsies of ACD patients. IL-1Ra and IL-36Ra expression was quantified in mononuclear cells of nickel-sensitized patients challenged in vitro with nickel. IL33-involvement in ACD was investigated by intradermal injection of anti-IL-33 in the uninvolved skin of patients ex vivo. Results showed that IL-1?, IL-1Ra, IL-36?, IL-36?, IL-36? and IL-33 expression, but not IL-36Ra expression was enhanced in ACD-involved skin. Immunohistochemical analysis and ex vivo skin cultures confirmed these results. Injection of anti-IL-33 in ACD-uninvolved skin inhibited IL-8 expression, whereas IL-36Ra inhibited IL-36?, IL-36?, IL-36? and IL-8 expression. Nickel induced IL-1Ra expression in lymphocytes of nickel-sensitized patients. In conclusion, various IL-1 agonists and antagonists may be involved in ACD pathogenesis.| File | Dimensione | Formato | |
|---|---|---|---|
|
Tesi%20Dottorato%20Martina%20Mattii.pdf
accesso solo da BNCF e BNCR
Tipologia:
Altro materiale allegato
Licenza:
Tutti i diritti riservati
Dimensione
988.38 kB
Formato
Adobe PDF
|
988.38 kB | Adobe PDF |
I documenti in UNITESI sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/20.500.14242/328039
URN:NBN:IT:BNCF-328039